Abstract
Ovarian cancer represents one of the most aggressive malignancies which is characterized by a high capacity of spread via multiple pathways such as lymphatic, peritoneal and hematogenous route, the most commonly encountered sites for metastatic lesions being represented by lung, liver, peritoneum and lymph nodes. In extremely rare cases breast metastases with ovarian origin have been reported. In such cases different therapeutic strategies have been proposed; however the overall prognosis remains extremely poor, the presence of metastatic lesions at this level being usually the sign of disseminated disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
